The challenge:
A privately-owned pharmaceutical company, based in the Levant, manufactures medicines and related products for well-known global firms. Prior to contacting Diligencia, they had established a sister company in the Middle East to manage the distribution of products in the region and to conduct due diligence on both their suppliers and distributors.
To effectively manage their risk exposure, the firm needed to research these partners and understand who their owners were and what, if any, cross-border connections they had.
The solution:
Following a successful trial of ClarifiedBy.com, Diligencia’s online platform, the pharmaceutical company approved an annual subscription, giving its compliance team instant access to our legal entity profiles, and began using the tool to review their entities of interest.
ClarifiedBy.com allows the client’s in-house team to research and analyse both companies and individuals, revealing UBOs, ownership structures, holdings and directorships, and to complete frequent screening checks. Our ability to deliver insight across over one hundred jurisdictions in the Middle East & Africa (MEA), in English and in the original source language of Arabic or Farsi, was a key reason that the client selected ClarifiedBy.com.
Furthermore, our intelligence provides an invaluable starting point for additional enhanced due diligence research or other analysis that may be required.
The result:
The client is an active user of ClarifiedBy.com, regularly using the platform to find core information and intelligence during its supplier, distributor and other business partner reviews.
The legal entity data and the consultancy services we offer, as an independent provider of intelligence on entities in the MEA region, are used to conduct crucial validation checks and to satisfy their stringent compliance requirements.
